Cat.#: ACPP-1744
| Despition | C1q Human Recombinant |
| SIZE | 200 µg |
| Purity | > 96.0%. |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1207 | Dopamine Receptor D1 Blocking Peptide (AC1207) | 250 µg | inquiry |
| ACPP-1783 | Human SAT2 Protein (AC1783) | 5 µg | inquiry |
| ACPP-1085 | Recombinant Human alpha Internexin Protein (AC1085) | 25 µl | inquiry |
| ACPP-1389 | AHSG (AC1389) | 10 µg | inquiry |
| ACPP-1310 | SHC Blocking Peptide (AC1310) | 250 µg | inquiry |
| ACPP-1631 | Human IMPDH1 Protein (AC1631) | 2 µg | inquiry |
| ACPP-1022 | Recombinant Human Integrin beta 1 Protein (Fc Tag) (AC1022) | 50 µg | inquiry |
| ACPP-1144 | Synthetic Nanodisc Human GIPR Protein (AC1144) | 10 µg | inquiry |
| ACPP-1496 | Human SPINT2 Protein (AC1496) | 2 µg | inquiry |
| ACPP-1671 | Human SPINT2 Protein, Sf9 (AC1671) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.